@article {van Dam1046, author = {P A van Dam and I B Vergote and G M Laekeman and G H Keersmaeckers and F L Uyttenbroeck and A G Herman}, title = {Prognostic value of prostaglandin F2 alpha concentrations in breast carcinoma.}, volume = {42}, number = {10}, pages = {1046--1048}, year = {1989}, doi = {10.1136/jcp.42.10.1046}, publisher = {BMJ Publishing Group}, abstract = {Prostaglandin F2 alpha (PGF2 alpha) concentrations were measured by radioimmunoassay in homogenised primary tumours from 57 patients with breast cancer. These patients were followed up from 60 to 78 months (median 63 months) after surgery and PGF2 alpha concentrations were related prospectively to metastatic spread and survival. The amounts of PGF2 alpha varied greatly in the different tumours (range 0-90 ng/mg protein), but no significant association was found between PGF2 alpha concentrations and disease free survival, time of relapse, site of recurrence, or overall survival. It therefore seems unlikely that measurement of PGF2 alpha in breast carcinoma is important in the prognosis of the disease.}, issn = {0021-9746}, URL = {https://jcp.bmj.com/content/42/10/1046}, eprint = {https://jcp.bmj.com/content/42/10/1046.full.pdf}, journal = {Journal of Clinical Pathology} }